Keep up to date with our latest partnering deals and highlights
Below is a selection of news releases describing recent deals completed by AstraZeneca and our biologics arm, MedImmune.
- Tuesday, 3 March 2015
- AstraZeneca and Cambridge Judge Business School announce collaboration to identify and support biotech start-ups AstraZeneca and the Cambridge Judge Business School at the University of Cambridge today announced an agreement to deliver a new “Accelerate Cambridge Life Sciences” programme at the business school which will identify, train and mentor start-up ventures in the life sciences.
- Monday, 8 December 2014
- AstraZeneca wins three business development awards at 10th Annual Scrip Awards 2014 AstraZeneca won three Scrip Awards at the 10th Annual Scrip Awards 2014, held in London, in the following categories: Best Partnership Alliance, Best Licensing Deal of the Year, and Best Management Team of the Year 2014.
- Tuesday, 16 September 2014
- AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease AstraZeneca and Eli Lilly and Company (Lilly) today announced an agreement to jointly develop and commercialise AZD3293